Literature DB >> 22379081

Protective role of interferon regulatory factor 3-mediated signaling against prion infection.

Daisuke Ishibashi1, Ryuichiro Atarashi, Takayuki Fuse, Takehiro Nakagaki, Naohiro Yamaguchi, Katsuya Satoh, Kenya Honda, Noriyuki Nishida.   

Abstract

Abnormal prion protein (PrP(Sc)) generated from the cellular isoform of PrP (PrP(C)) is assumed to be the main or sole component of the pathogen, called prion, of transmissible spongiform encephalopathies (TSE). Because PrP is a host-encoded protein, acquired immune responses are not induced in TSE. Meanwhile, activation of the innate immune system has been suggested to partially block the progression of TSE; however, the mechanism is not well understood. To further elucidate the role of the innate immune system in prion infection, we investigated the function of interferon regulatory factor 3 (IRF3), a key transcription factor of the MyD88-independent type I interferon (IFN) production pathway. We found that IRF3-deficient mice exhibited significantly earlier onset with three murine TSE strains, namely, 22L, FK-1, and murine bovine spongiform encephalopathy (mBSE), following intraperitoneal transmission, than with wild-type controls. Moreover, overexpression of IRF3 attenuated prion infection in the cell culture system, while PrP(Sc) was increased in prion-infected cells treated with small interfering RNAs (siRNAs) against IRF3, suggesting that IRF3 negatively regulates PrP(Sc) formation. Our findings provide new insight into the role of the host innate immune system in the pathogenesis of prion diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22379081      PMCID: PMC3347345          DOI: 10.1128/JVI.06326-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

Review 1.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.

Authors:  S Goodbourn; L Didcock; R E Randall
Journal:  J Gen Virol       Date:  2000-10       Impact factor: 3.891

2.  Dual utilization of an acceptor/donor splice site governs the alternative splicing of the IRF-3 gene.

Authors:  A Y Karpova; P M Howley; L V Ronco
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

3.  Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.

Authors:  N Nishida; D A Harris; D Vilette; H Laude; Y Frobert; J Grassi; D Casanova; O Milhavet; S Lehmann
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 4.  Detection of PrP in extraneural tissues.

Authors:  K L Brown; D L Ritchie; P A McBride; M E Bruce
Journal:  Microsc Res Tech       Date:  2000-07-01       Impact factor: 2.769

5.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.

Authors:  M Sato; H Suemori; N Hata; M Asagiri; K Ogasawara; K Nakao; T Nakaya; M Katsuki; S Noguchi; N Tanaka; T Taniguchi
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

6.  Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.

Authors:  Déborah Tribouillard-Tanvier; James F Striebel; Karin E Peterson; Bruce Chesebro
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells.

Authors:  Brian P Doehle; Florian Hladik; John P McNevin; M Juliana McElrath; Michael Gale
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

Review 8.  Multiple signaling pathways leading to the activation of interferon regulatory factor 3.

Authors:  Marc J Servant; Nathalie Grandvaux; John Hiscott
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

9.  Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice.

Authors:  Yuval Tal; Lina Souan; Irun R Cohen; Zeev Meiner; Albert Taraboulos; Felix Mor
Journal:  J Neurosci Res       Date:  2003-01-15       Impact factor: 4.164

10.  Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration.

Authors:  Robert Field; Suzanne Campion; Colleen Warren; Carol Murray; Colm Cunningham
Journal:  Brain Behav Immun       Date:  2010-04-23       Impact factor: 7.217

View more
  21 in total

Review 1.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

2.  Efficacy and mechanism of a glycoside compound inhibiting abnormal prion protein formation in prion-infected cells: implications of interferon and phosphodiesterase 4D-interacting protein.

Authors:  Keiko Nishizawa; Ayumi Oguma; Maki Kawata; Yuji Sakasegawa; Kenta Teruya; Katsumi Doh-ura
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

3.  Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice.

Authors:  Daisuke Ishibashi; Takeshi Ishikawa; Satoshi Mizuta; Hiroya Tange; Takehiro Nakagaki; Tsuyoshi Hamada; Noriyuki Nishida
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 4.  The immunobiology of prion diseases.

Authors:  Adriano Aguzzi; Mario Nuvolone; Caihong Zhu
Journal:  Nat Rev Immunol       Date:  2013-11-05       Impact factor: 53.106

5.  Ubiquitin-specific protease 14 modulates degradation of cellular prion protein.

Authors:  Takujiro Homma; Daisuke Ishibashi; Takehiro Nakagaki; Takayuki Fuse; Tsuyoshi Mori; Katsuya Satoh; Ryuichiro Atarashi; Noriyuki Nishida
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

6.  Prion pathogenesis in the absence of NLRP3/ASC inflammasomes.

Authors:  Mario Nuvolone; Silvia Sorce; Petra Schwarz; Adriano Aguzzi
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

7.  Increased expression of p62/SQSTM1 in prion diseases and its association with pathogenic prion protein.

Authors:  Takujiro Homma; Daisuke Ishibashi; Takehiro Nakagaki; Katsuya Satoh; Kazunori Sano; Ryuichiro Atarashi; Noriyuki Nishida
Journal:  Sci Rep       Date:  2014-03-28       Impact factor: 4.379

8.  Protective role of MyD88-independent innate immune responses against prion infection.

Authors:  Daisuke Ishibashi; Ryuichiro Atarashi; Noriyuki Nishida
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

9.  Prion pathogenesis and secondary lymphoid organs (SLO): tracking the SLO spread of prions to the brain.

Authors:  Neil A Mabbott
Journal:  Prion       Date:  2012-08-16       Impact factor: 3.931

10.  Strain-Dependent Effect of Macroautophagy on Abnormally Folded Prion Protein Degradation in Infected Neuronal Cells.

Authors:  Daisuke Ishibashi; Takujiro Homma; Takehiro Nakagaki; Takayuki Fuse; Kazunori Sano; Hanae Takatsuki; Ryuichiro Atarashi; Noriyuki Nishida
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.